Targeted molecular therapy of malignant gliomas
β Scribed by Santosh Kesari; Naren Ramakrishna; Claire Sauvageot; Charles D. Stiles; Patrick Y. Wen
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 933 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1528-4042
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Malignant gliomas are relatively uncommon but lethal cancers. Despite recent research efforts in cancer therapy, the prognosis of patients with malignant gliomas has remained dismal. Understanding the molecular pathogenesis of glioma may lead to a rational development of new therapies.
Hexokinase plays an important role in glucose-utilizing tissues like normal brain and cancers. In these tissues, hexokinase (HK) is mainly bound to mitochondria (mHK). Our objectives were to evaluate total HK (tHK) activity and mHK fraction in gliomas and to determine whether mHK binding could be ta